New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ProSomnus, Inc. Common Stock
OSA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

8M

Medical - Devices

0.47USD
Shape-0.04 ( -7.35%)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-8%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

91%
OverviewChart

Quote Panel

Shape
Updated October 27, 2024
1W % 1M % 3M % 1Y -25.40 %

Key Metrics

Shape

  • Market Cap

    8.18M

  • Shares Outstanding

    17.39M

  • Share in Float

    8.09M

  • Dividende

    0

  • Earning Date

    No Data

  • Price Target

    0.47

  • Average Volume

    64053

  • Beta

    0.211

  • Range

    0.345-5.25

  • Industry

    Medical - Devices

  • Website

    https://prosomnus.com

  • Sector

    Healthcare

Fundamentals

Shape

N/A

P/E Ratio

0.28x

P/S Ratio

-0.36x

P/B Ratio

-1.6

Debt/Equity

-47.0%

Net Margin

$-1.5

EPS

How OSA compares to sector?

P/E Ratio

OSA

-1x

LIVN -173x
ELMD 39x
KIDS -24x
SRDX -381x
NPCE -6x

Relative Strength

Shape

OSA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$43M

Shape473%

2025-Revenue

$0.60

Shape-400%

2025-EPS

$20M

Shape-1043%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.18
vs -0.05

Q3.22

arrow
arrow

N/A

-0.19
vs -0.07

Q4.22

arrow
arrow

+510%

0.56
vs -0.14

Q1.23

arrow
arrow

N/A

-0.36
vs -0.19

Q2.23

arrow
arrow

N/A

-0.43
vs -0.18

Q3.23

arrow
arrow

N/A

-0.61
vs -0.19

Q4.23

arrow
arrow

N/A

-0.42
vs 0.56

Q1.24

arrow
arrow

+115%

0.05
vs -0.36

Q3.24

arrow
arrow

N/A

-0.21
vs -0.61

Q4.24

arrow
arrow

N/A

-0.19
vs -0.42

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+41%

4.9M  vs 3.4M

Q3.22

arrow
arrow

+35%

5M  vs 3.7M

Q4.22

arrow
arrow

+32%

5.8M  vs 4.4M

Q1.23

arrow
arrow

+55%

5.8M  vs 3.7M

Q2.23

arrow
arrow

+43%

6.9M  vs 4.9M

Q3.23

arrow
arrow

+41%

7.1M  vs 5M

Q4.23

arrow
arrow

+35%

7.8M  vs 5.8M

Q1.24

arrow
arrow

+28%

7.5M  vs 5.8M

Q3.24

arrow
arrow

+16%

8.2M  vs 7.1M

Q4.24

arrow
arrow

+14%

8.9M  vs 7.8M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+5%

0.05
vs NA

Q3.22

arrow
arrow

+5%

0.05
vs 0.05

Q4.22

arrow
arrow

-44%

-0.44
vs 0.05

Q1.23

arrow
arrow

+31%

0.31
vs -0.44

Q2.23

arrow
arrow

-4%

-0.04
vs 0.31

Q3.23

arrow
arrow

+34%

0.34
vs -0.04

Q4.23

arrow
arrow

+26%

0.26
vs 0.34

Q1.24

arrow
arrow

-15%

-0.15
vs 0.26

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

OSA

seekingalpha.com

less than 1 hour ago

ProSomnus, Inc. (OSA) Q4 2023 Earnings Call Transcript
OSA

benzinga.com

7 hours ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
OSA

businesswire.com

8 hours ago

Adtran sets new industry benchmarks with optical pumping cesium atomic clocks
OSA

prnewswire.com

15 hours ago

Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution
OSA

globenewswire.com

16 hours ago

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
OSA

globenewswire.com

20 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

New Feature Coming Soon, Stay Tuned!

ShapeShape